指南与共识前列腺癌

基于EAU指南预测高危前列腺癌辅助放疗指征的多变量模型

Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model.
指南 / 共识 · Prostate Cancer Prostatic Dis · 2025-09-03

该研究基于单中心数据库纳入5691例高危前列腺癌患者,开发术前预测根治性前列腺切除术后辅助放疗指征的多变量模型。结果显示38%患者符合EAU 2025指南辅助放疗指征,模型c-index为0.761(95%CI 0.749-0.776),需外部验证后应用。

要点

  • 38%高危前列腺癌患者符合EAU 2025指南辅助放疗指征。
  • 预测模型纳入前列腺体积、PSA、临床分期、穿刺针数、阳性比例和Gleason分级。
  • 模型c-index为0.761,尚需外部验证。

核心结论

  • 临床肿瘤特征可用于术前预测高危前列腺癌患者根治性前列腺切除术后符合EAU指南辅助放疗指征。
  • 该多变量模型在临床应用前需在独立队列中进行外部验证。

研究设计与样本

  • 基于单中心大容量数据库(2010年1月至2024年8月)识别高危前列腺癌患者。
  • 共纳入5691例患者,采用单变量和多变量逻辑回归模型分析辅助放疗指征的预测因素。
  • 使用Harrell一致性指数(c-index)经2000次bootstrap重采样进行内部验证评估模型准确性。

主要发现

  • 5691例患者中2137例(38%)符合当前EAU 2025指南辅助放疗指征。
  • 辅助放疗指征与前列腺体积>45 cm³和25-45 cm³、PSA>20 ng/ml和10-20 ng/ml、临床分期cT3/4和cT2、穿刺针数≤12、阳性穿刺比例较高及穿刺Gleason分级分组5、4、3相关。
  • 年龄和体重指数与辅助放疗指征无关联。
  • 多变量模型预测辅助放疗指征的c-index为0.761(95%CI 0.749-0.776)。

临床怎么用

  • 对于高危前列腺癌患者,可基于术前临床肿瘤特征评估根治性前列腺切除术后辅助放疗指征。
  • 该模型需外部验证后方可用于临床决策。

局限性

  • 模型仅进行内部验证,需在独立队列中进行外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To develop a novel model for preoperatively predicting the indication for adjuvant radiation therapy after radical prostatectomy according to current guideline recommendations of the European Association of Urology (EAU) based on patient and clinical tumor characteristics in high-risk prostate cancer patients. METHODS: Within a high-volume center database (01/2010-08/2024), we identified high-risk prostate cancer patients. Univariable logistic regression models addressed indication for adjuvant radiation therapy. Multivariable logistic regression models included the most informative, statistically significant preoperative predictors. Harrell's concordance index (c-index) quantified accuracy after 2000 bootstrap resamples for internal validation. RESULTS: Of 5691 patients, 2137 (38%) had indication for adjuvant radiation therapy according to current EAU guidelines (2025). Indication for adjuvant radiation therapy was associated with higher prostate volume (> 45 cm3 and 25-45 cm3) and advanced tumor characteristics, namely higher prostate-specific antigen value (>20 ng/ml and 10-20 ng/ml), advanced clinical tumor stage (cT3/4 and cT2), lower number of sampled biopsy cores (≤ 12), higher proportion of positive cores (continuous), and higher Gleason Grade Group in biopsy (5, 4, and 3). No association was observed for age and body-mass index and indication for adjuvant radiation therapy. Multivariable model c-index for the prediction of the indication for adjuvant radiation therapy was 0.761 (95% confidence interval 0.749-0.776). CONCLUSIONS: Clinical tumor characteristics can be used for preoperatively predicting the indication for adjuvant radiation therapy after radical prostatectomy according to current EAU guideline recommendations in high-risk prostate cancer patients. Prior to clinical application, the present multivariable model should be externally validated within an independent cohort.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Siech C, von Kriegstein H, Wenzel M, et al. Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model. Prostate Cancer Prostatic Dis. 2025. PMID: 40897826. doi:10.1038/s41391-025-01018-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。